<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-06-02">June 2, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Jacob</forename><forename type="middle">C</forename><surname>Ulirsch</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">The Manton Center for Orphan Disease Research</orgName>
								<orgName type="department" key="dep3">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep4">Dana-Farber Cancer Institute</orgName>
								<orgName type="institution" key="instit1">Boston Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Satish</forename><forename type="middle">K</forename><surname>Nandakumar</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">The Manton Center for Orphan Disease Research</orgName>
								<orgName type="department" key="dep3">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep4">Dana-Farber Cancer Institute</orgName>
								<orgName type="institution" key="instit1">Boston Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Li</forename><surname>Wang</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Felix</forename><forename type="middle">C</forename><surname>Giani</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">The Manton Center for Orphan Disease Research</orgName>
								<orgName type="department" key="dep3">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep4">Dana-Farber Cancer Institute</orgName>
								<orgName type="institution" key="instit1">Boston Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xiaolan</forename><surname>Zhang</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Rogov</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alexandre</forename><surname>Melnikov</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Patrick</forename><surname>Mcdonel</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Genetics and Genomic Sciences</orgName>
								<orgName type="department" key="dep2">Icahn School of Medicine at Mount Sinai</orgName>
								<orgName type="institution">The Charles Bronfman Institute for Personalized Medicine</orgName>
								<address>
									<postCode>10029</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ron</forename><surname>Do</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Tarjei</forename><forename type="middle">S</forename><surname>Mikkelsen</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">Harvard Stem Cell Institute</orgName>
								<address>
									<postCode>02138</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Vijay</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
							<email>sankaran@broadinstitute.org</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">The Manton Center for Orphan Disease Research</orgName>
								<orgName type="department" key="dep3">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep4">Dana-Farber Cancer Institute</orgName>
								<orgName type="institution" key="instit1">Boston Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">Harvard Stem Cell Institute</orgName>
								<address>
									<postCode>02138</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-06-02">June 2, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">07E002272C2643B36AE35200C6DEA43F</idno>
					<idno type="DOI">10.1016/j.cell.2016.04.048</idno>
					<note type="submission">Received: July 7, 2015 Revised: November 12, 2015 Accepted: April 12, 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:49+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Genome-wide association studies (GWAS) have successfully identified thousands of associations between common genetic variants and human disease phenotypes, but the majority of these variants are non-coding, often requiring genetic fine-mapping, epigenomic profiling, and individual reporter assays to delineate potential causal variants.</s><s>We employ a massively parallel reporter assay (MPRA) to simultaneously screen 2,756 variants in strong linkage disequilibrium with 75 sentinel variants associated with red blood cell traits.</s><s>We show that this assay identifies elements with endogenous erythroid regulatory activity.</s><s>Across 23 sentinel variants, we conservatively identified 32 MPRA functional variants (MFVs).</s><s>We used targeted genome editing to demonstrate endogenous enhancer activity across 3 MFVs that predominantly affect the transcription of SMIM1, RBM38, and CD164.</s><s>Functional follow-up of RBM38 delineates a key role for this gene in the alternative splicing program occurring during terminal erythropoiesis.</s><s>Finally, we provide evidence for how common GWAS-nominated variants can disrupt cell-type-specific transcriptional regulatory pathways.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Genome-wide association studies (GWAS) have successfully identified over 10,000 common SNPs associated with hundreds of human traits and diseases <ref type="bibr" target="#b54">(Welter et al., 2014)</ref>.</s><s>Each GWAS ''hit'' usually represents, or tags, hundreds of variants that are inherited together across a large (many are up to $0.5 megabase) genomic region, termed a linkage disequilibrium (LD) block, often containing numerous protein-coding genes <ref type="bibr" target="#b34">(Raychaudhuri, 2011)</ref>.</s><s>It is estimated that $80% of the phenotypic heritability in common diseases and traits can be explained by non-coding regulatory variants (85%-90% of GWAS hits tag only non-coding variants) <ref type="bibr" target="#b11">(Gusev et al., 2014)</ref>, making targetgene identification and subsequent biological inference a considerable challenge <ref type="bibr" target="#b7">(Edwards et al., 2013;</ref><ref type="bibr" target="#b54">Welter et al., 2014)</ref>.</s><s>However, these GWAS-nominated variants are significantly enriched at cell-type-specific regulatory regions such as DNase I hypersensitivity sites (DHS) and transcription factor (TF) occupancy sites, suggesting the attractive hypothesis that many of these variants may alter the regulation of gene transcription <ref type="bibr" target="#b19">(Kundaje et al., 2015;</ref><ref type="bibr" target="#b42">Schaub et al., 2012)</ref>.</s></p><p><s>Firmly establishing the causality of a GWAS-nominated regulatory variant requires clearly demonstrating its molecular functionality, identifying its target gene(s), and proving a connection to the original phenotype.</s><s>Typically, identifying putative causal regulatory variants from GWAS requires a combination of genetic fine mapping, epigenomic profiling, and individual reporter assays <ref type="bibr" target="#b7">(Edwards et al., 2013)</ref>.</s><s>Moving from putative causal variant (PCV) to target gene is facilitated either by expression quantitative trait loci (eQTL) studies in appropriate tissues or by creating isogenic cellular models (e.g., via genome editing) to identify the target gene(s).</s><s>A target gene is then modulated in vitro in primary cell culture or in vivo in animal models to identify its role in determining the original phenotype.</s><s>In a small number of cases, systematic approaches have successfully identified PCV(s), their mechanisms of action, target gene(s), and biological relevance for individual GWAS hits <ref type="bibr" target="#b0">(Bauer et al., 2013;</ref><ref type="bibr" target="#b3">Claussnitzer et al., 2015;</ref><ref type="bibr" target="#b7">Edwards et al., 2013;</ref><ref type="bibr" target="#b29">Musunuru et al., 2010;</ref><ref type="bibr" target="#b38">Sankaran et al., 2008</ref><ref type="bibr" target="#b41">Sankaran et al., , 2012b))</ref>.</s></p><p><s>In order to better understand the underlying biology behind an exponentially growing number of genetic associations, the development of scalable and high-throughput approaches is necessary.</s><s>A recent study investigated loci associated with several autoimmune disorders by integrating finely mapped genetic associations from over 25,000 individuals with extensive enhancer annotations for 56 potentially relevant cell types, identifying a large number of PCVs <ref type="bibr" target="#b9">(Farh et al., 2015)</ref>.</s><s>Nevertheless, this method resulted in identification of a single PCV for only $10% of genetic associations.</s><s>Other creative approaches acknowledge the expense and difficulty of genetic and epigenetic fine mapping and have leveraged phylogenetic information to screen for causal variants, although these approaches are limited due to the relatively rapid evolutionary turnover of TFbinding motifs <ref type="bibr" target="#b2">(Claussnitzer et al., 2014)</ref>.</s><s>However, neither of these approaches provides a systematic method to functionally assess the regulatory activity of all variants at these loci.</s></p><p><s>To address the need for high-throughput functional screening of GWAS loci, we utilized a massively parallel reporter assay (MPRA) to simultaneously screen for regulatory effects in 2,756 variants in high LD with 75 GWAS hits from a comprehensive study of red blood cell (RBC) traits <ref type="bibr" target="#b27">(Melnikov et al., 2012;</ref><ref type="bibr" target="#b32">Patwardhan et al., 2012;</ref><ref type="bibr" target="#b51">van der Harst et al., 2012)</ref>.</s><s>We chose to investigate loci associated with variation in RBC traits as a model for common genetic variation, given our prior success in identifying and following up on GWAS hits associated with such traits <ref type="bibr" target="#b10">(Giani et al., 2016;</ref><ref type="bibr" target="#b24">Ludwig et al., 2015;</ref><ref type="bibr" target="#b38">Sankaran et al., 2008</ref><ref type="bibr" target="#b41">Sankaran et al., , 2012b))</ref>.</s><s>For example, such studies have resulted in the identification and characterization of the key fetal hemoglobin silencer BCL11A, an attractive therapeutic target for sickle cell disease and b-thalassemia <ref type="bibr" target="#b38">(Sankaran et al., 2008;</ref><ref type="bibr" target="#b37">Sankaran and Weiss, 2015)</ref>.</s><s>Here, we used our MPRA to identify 32 functional variants representing 23 ($30%) of the original 75 GWAS hits (median of 1 variant/GWAS hit) and estimate a positive predictive value (PPV) between 32% and 50% for identifying PCVs.</s><s>We used targeted CRISPR/Cas9 genome editing to confirm the endogenous activity of the regulatory elements containing a subset of these variants.</s><s>For three variants, we determined their target genes and suggest mechanisms of action.</s><s>Follow-up on the target gene RBM38 revealed its key role in alternative splicing during terminal erythropoiesis, as well as its relevance to the phenotypes originally reported in the GWAS.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Designing an MPRA to Screen GWAS Variants</head><p><s>We selected 2,756 SNPs or small indels that were in high LD (R 2 &gt; 0.8) with 75 previously reported GWAS hits to include in a highthroughput screen (Table <ref type="table">S1</ref>).</s><s>These variants were identified in the most comprehensive analysis to date that measured the effects of genetic variation on RBC traits, comprising over 135,000 cases from over 30 individual studies <ref type="bibr" target="#b51">(van der Harst et al., 2012)</ref>.</s><s>Positive control variants that disrupt the binding site of the erythroid TF GATA1 in an erythroid enhancer element, resulting in vivo in severe human erythroid disorders, were also included <ref type="bibr" target="#b1">(Campagna et al., 2014;</ref><ref type="bibr" target="#b17">Kaneko et al., 2014;</ref><ref type="bibr" target="#b25">Manco et al., 2000;</ref><ref type="bibr" target="#b46">Solis et al., 2001)</ref>.</s><s>We modified a recently designed MPRA to screen medium-sized segments of DNA ($145 bp) containing each variant of interest <ref type="bibr" target="#b27">(Melnikov et al., 2012)</ref> (Figure <ref type="figure" target="#fig_0">1A</ref>).</s><s>For each allele (major/minor), we synthesized constructs across three sliding windows (SWs) <ref type="bibr">(''left,'' ''middle,'' and ''right'')</ref> in order to vary the genomic context and maximize the chances of isolating key regulatory elements.</s><s>Each construct was assigned 14 unique, designed barcodes.</s><s>Constructs were ligated into a plasmid backbone, and an inert open reading frame (ORF) with a minimal promoter (TATA) was ligated 3 0 of the constructs and 5 0 of the barcodes to produce the final pooled library of constructs.</s></p><p><s>To measure the activity of each construct, the library was transfected into an erythroid cell line, mRNA was isolated and reverse transcribed, PCR amplification was performed on the 3 0 end surrounding the barcode, and the PCR products were deep sequenced to determine barcode representation <ref type="bibr">(Figure 1A)</ref>.</s><s>DNA was isolated and sequenced from the plasmid library to determine the relative abundance of each construct in the library.</s><s>Thus, an mRNA/DNA ratio aggregated across each barcode represents the activity for the tagged construct.</s><s>Although most barcodes were abundant in the pooled library (&gt;80%), those with low representation were excluded, resulting in the inclusion of 95% of the original constructs in subsequent analyses (Figure <ref type="figure" target="#fig_0">1B</ref>).</s><s>Activity estimates were highly correlated across all replicates (Figure <ref type="figure" target="#fig_0">1C</ref>), whereas activity across SWs was only moderately correlated (Figure <ref type="figure" target="#fig_0">S1A</ref>).</s><s>Importantly, we did not observe that barcode biases substantially affected our activity estimates (Figure <ref type="figure" target="#fig_0">S1B</ref>).</s></p><p><s>Common Genetic Variation Associated with RBC Traits Intrinsically Affects the Erythroid Lineage Reporter assays display cell-type-specific activity <ref type="bibr" target="#b29">(Musunuru et al., 2010;</ref><ref type="bibr" target="#b41">Sankaran et al., 2012b)</ref>, highlighting the critical importance of identifying an appropriate cellular model for an MPRA screen.</s><s>We performed multiple analyses to identify the primary cell type in which common genetic variation associated with RBC traits is most likely to act.</s></p><p><s>We first investigated a compendium of 79 diverse human tissues for cell-type-specific gene expression proximal to LD blocks containing the GWAS hits <ref type="bibr" target="#b48">(Su et al., 2004)</ref>.</s><s>Transferrin receptor (CD71) positive human erythroid progenitors/precursors (HEPs) from the bone marrow were identified as the most significantly enriched cell type (Figure <ref type="figure" target="#fig_3">2A</ref>).</s><s>To more finely identify the exact state(s) of hematopoietic differentiation where transcription could be affected by GWAS variants, we investigated 38 cell types representing the major stages of human hematopoietic differentiation and identified three distinct stages of glycophorin A (GlyA) positive HEPs as the most enriched (Figure <ref type="figure" target="#fig_3">2B</ref>) <ref type="bibr" target="#b30">(Novershtern et al., 2011)</ref>.</s><s>Importantly, we observed that these variants are most significantly enriched for regulatory regions identified by open chromatin in erythroid cells compared with other cell types <ref type="bibr" target="#b19">(Kundaje et al., 2015)</ref> (Figure <ref type="figure" target="#fig_3">2C</ref>), suggesting that many of these variants may affect transcription by altering regulatory activity in HEPs.</s></p><p><s>Key experimental factors for an MPRA screen are that the reproducibility of barcode counts is dependent upon high transfection efficiency and starting cell numbers scale linearly with library complexity (here $231,000 elements) <ref type="bibr" target="#b27">(Melnikov et al., 2012)</ref>.</s><s>Thus, we excluded performing MPRA in primary erythroid cells derived from donor CD34 + human hematopoietic stem and progenitor cells (HSPCs), which are limited in total numbers and display considerable heterogeneity in terms of stage of differentiation <ref type="bibr" target="#b14">(Hu et al., 2013)</ref>, as this would likely result in poor-quality data.</s><s>We determined that the human erythroid cell line K562 was a suitable cellular model in which to perform the MPRA as a result of multiple features.</s><s>First, K562 gene expression is similar to that of HEPs (Figure <ref type="figure" target="#fig_3">2E</ref>).</s><s>Second, K562 cells share similar open chromatin (agnostic to promoter or enhancer demarcations) with HEPs based upon hierarchical clustering across 54 cell types and show greater than 70% overlap with RBC trait GWAS hits at these regulatory elements (Figures <ref type="figure" target="#fig_3">2C and 2D</ref>).</s><s>that reporter assays in K562 cells are capable of identifying genetic variants with erythroid-specific effects <ref type="bibr" target="#b41">(Sankaran et al., 2012b)</ref>.</s></p><p><s>Because our analyses suggested that these variants are enriched for both earlier-stage (CD71 + ) and later-stage (GlyA + ) HEPs, we wanted to model each variant's effect in earlier and later erythroid cell states.</s><s>Standard K562 cells exhibit an expression profile most similar to that of an early erythroid precursor (proerythroblast, ProE; Figure <ref type="figure" target="#fig_3">2E</ref>).</s><s>We determined that the key erythroid TF GATA1 is differentially expressed between these two conditions (orthochromatophilic erythroblast, OrthoE [GlyA + ] versus ProE [CD71 + ]) (Figure <ref type="figure" target="#fig_3">2G</ref>).</s><s>Upon overexpression of GATA1, we were able to induce a more terminal erythroid gene signature (Figures <ref type="figure" target="#fig_3">2H and 2I</ref>), highlighted by the upregulation of crucial erythroid TFs, such as KLF1 (Figure <ref type="figure" target="#fig_3">2J</ref>).</s><s>Thus, we performed our MPRA in both standard K562 cells, resembling an earlier HEP, and K562+GATA1 cells, resembling a more differentiated HEP (Figure <ref type="figure" target="#fig_0">1C</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MPRA Identifies Endogenous Regulatory Elements</head><p><s>We first investigated the activity of each control element, derived from regulatory elements mutated (GATA1 motif disruption) in human Mendelian erythroid disorders <ref type="bibr" target="#b53">(Wakabayashi et al., 2016)</ref>.</s><s>In each case, the reference (Ref), non-mutated control construct showed strong enhancer-like activity in our assay (top 1% of all constructs for at least one SW).</s><s>Moreover, at a false discovery rate (FDR) of 1%, all control mutants   exhibited decreased activity in our assay across at least one SW <ref type="bibr">(Figures 3A and S3A)</ref>.</s><s>Having confirmed that we could identify active regulatory elements, we examined all active constructs (ACs) identified in our assay.</s><s>These ACs, defined as elements with activity significantly greater than the activity distribution formed from all investigated constructs (FDR &lt; 1%) and representing fewer than 4% of tested constructs, show a similar activity distribution to non-mutated controls (Figures <ref type="figure" target="#fig_4">3B and S3B</ref>).</s></p><p><s>Inactive constructs show activity similar to, but slightly lower than, control mutants, suggesting that whereas most inactive constructs have limited regulatory activity, disruptions in strong regulatory elements due to single-base mutations retain partial regulatory/enhancer-like activity (Figure <ref type="figure" target="#fig_4">3B</ref>).</s><s>Given that MPRA is an exogenous assay, we investigated the overlap of ACs with endogenous regulatory elements in both HEPs and K562 cells.</s><s>We found that ACs were significantly enriched for open chromatin in erythroid cell types compared to inactive constructs or to $10,000 unrelated GWAS hits (background SNPs) (Figures <ref type="figure" target="#fig_4">3E and S3D</ref>).</s><s>Although many of these regulatory regions are shared across multiple tissues (median overlap 8/54, 14% of all tissues), ACs showed the greatest overlap with erythroid cell types (Figure <ref type="figure" target="#fig_4">3F</ref>).</s><s>ACs were also significantly enriched for chromatin occupancy of the erythroid TF GATA1 and its co-factor TAL1.</s><s>When we trained a 6-mer support vector machine on the underlying DNA sequences <ref type="bibr" target="#b20">(Lee et al., 2011)</ref>, we identified known erythroid TF-binding motifs, including GATA1, TAL1, ETS/FLI1, and AP-1/NFE2, as most predictive of high activity (Figure <ref type="figure" target="#fig_4">3D</ref>).</s><s>Moreover, this model shows high discriminatory ability to correctly classify constructs as active or inactive (Figures <ref type="figure" target="#fig_4">3C and S3C</ref>).</s><s>Together, these findings show that MPRA can correctly identify regulatory elements that exhibit activity in the endogenous genomic setting and suggest that differences in MPRA activity likely represent changes in binding or activity of cell-type-specific TFs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Identifying MPRA Functional Variants</head><p><s>We next set out to identify constructs that show significant allelic variation in activity.</s><s>In a combined analysis of both cell types, out of 8,268 constructs (3 SWs for 2,756 variants) we identified 43 constructs containing 32 variants with differential allelic activity (FDR &lt; 1%).</s><s>These 32 variants, termed MPRA functional variants or MFVs, represent 31% (23/75) of the GWAS hits with a median of 1 MFV per GWAS hit (Figure <ref type="figure" target="#fig_4">3G</ref> and Table <ref type="table">S2</ref>).</s><s>On average, the effect sizes of the MFVs were moderate (mean log 2 -fold change of 1.28) (Figure <ref type="figure" target="#fig_4">3G</ref>), and variants identified as MFVs had better barcode representation than non-MFVs (nMFVs) (mean 27.2 versus 23.2 out of 28 possible).</s></p><p><s>In order to better understand the set of MFVs identified by our assay, we first used orthogonal evidence to infer their regulatory functionality.</s><s>Similar to ACs, MFVs are most enriched for regions of open chromatin in both primary HEPs and K562 cells when compared to other cell types (Figures <ref type="figure" target="#fig_4">3H and S3E</ref>).</s><s>Although most variants lie within fairly cell-type-specific regulatory elements (median 6/54 cell types), some variants fall in ubiquitous elements (Figure <ref type="figure" target="#fig_4">S3E</ref>).</s><s>Similar to previous studies <ref type="bibr" target="#b9">(Farh et al., 2015)</ref>, only 63% (20/32) of MFVs overlap with open chromatin in at least one of the 54 assayed cell types, suggesting the possibility that some variants may act in unassayed cell types or in regulatory regions not captured by open chromatin profiling (alternatively, these variants could be false positives).</s></p><p><s>Strikingly, we observe a strong enrichment for erythroid TF occupancy, including GATA1 and TAL1 (Figure <ref type="figure" target="#fig_4">3H</ref>).</s><s>In order to determine whether the activity of certain MFVs was dependent upon GATA1 levels, we compared activity for each construct between K562 and K562+GATA1 MPRA experiments (Figure <ref type="figure" target="#fig_4">S3G</ref> and Table <ref type="table">S3</ref>).</s><s>Intriguingly, the group of MFVs was significantly enriched for constructs that exhibit a dosage-dependent response to GATA1 (Figures <ref type="figure" target="#fig_4">3J and S3G</ref>).</s><s>As a control, we show that the Mendelian constructs with mutated GATA1 motifs do not change in activity with increased GATA1 expression, whereas those with an intact GATA1 motif substantially increase (Figures <ref type="figure" target="#fig_4">3K and S3G</ref>).</s></p><p><s>As a number of innovative algorithms that can predict the regulatory function of a variant have recently been developed and validated, we applied a subset of these to our 32 MFVs in order to determine whether the set of MFVs is indeed enriched for functional regulatory variants.</s><s>General algorithms without allelic directionality, including Eigen and DeepSea's FunSig, assign higher functional scores to MFVs when compared to all tested variants or to ACs containing variants that do not show allelic skew (AC/nMFV) (Figure <ref type="figure" target="#fig_4">S3F</ref>) <ref type="bibr" target="#b16">(Ionita-Laza et al., 2016;</ref><ref type="bibr" target="#b57">Zhou and Troyanskaya, 2015)</ref>.</s><s>Algorithms with directionality, including delta-SVM and DeepSea, are trained on cell-type-specific data and provide better separation (Figure <ref type="figure" target="#fig_4">S3F</ref>) <ref type="bibr" target="#b21">(Lee et al., 2015;</ref><ref type="bibr" target="#b57">Zhou and Troyanskaya, 2015)</ref>.</s><s>Importantly, the size and direction of MFV allelic skew predicted by these algorithms are strongly correlated with MPRA fold changes (Figures <ref type="figure" target="#fig_4">3L and 3M</ref>).</s><s>Collectively, the DHS and TF overlap coupled with the predictive  (legend continued on next page)</s></p><p><s>Cell 165, 1530-1545, June 2, 2016 1535 algorithm results suggest that our set of MFVs is enriched for functional regulatory variants.</s></p><p><s>We next sought to determine the extent to which our set of MFVs was enriched for causal variants.</s><s>Of the 32 MFVs, only 2 are sentinel variants (9%), similar to findings of previous studies <ref type="bibr" target="#b9">(Farh et al., 2015)</ref>.</s><s>In order to determine the amount of genetic evidence supporting each tested variant, we applied the previously validated PICS algorithm for genetic fine-mapping to estimate the probability that each variant is causal and determined that our set of MFVs was indeed enriched for PCVs (Figure <ref type="figure" target="#fig_4">S3F</ref>) <ref type="bibr" target="#b9">(Farh et al., 2015)</ref>.</s><s>To derive a more quantitative measure, we reasoned that we could estimate an empirical PPV for our assay by comparing the enrichment of MFVs between a credible set and a non-credible set of variants (e.g., a 60% credible set will contain the causal variant 60% of the time; see Supplemental Experiment Procedures).</s><s>Using PICS probabilities, we derived 80%, 90%, and 95% credible sets and observed a consistent enrichment of 1.47-to 1.58-fold for MFVs in these credible sets, resulting in an estimated PPV of 32%-37%.</s></p><p><s>As an alternative estimate of the PPV, we used the expectation that the directionality of MPRA allelic skew should in general correspond to the direction of a variant's endogenous regulatory effects.</s><s>We thus compared the directionality concordance between MPRA fold changes and the allele-specific activity predictions from delta-SVM and DeepSea (Figures <ref type="figure" target="#fig_4">3L and 3M</ref>).</s><s>These two algorithms agree on directionality substantially more than expected by chance (69%-75% agreement versus 50% expected), resulting in an empirical PPV of 38%-50%.</s><s>To illustrate the specificity of this approach, we observe only a small improvement in agreement for AC/nMFVs (54%-55% agreement versus 50% expected).</s></p><p><s>Using the inclusive PPV range of 32%-50% and making the assumption that there is only one causal variant for each GWAS association, we estimate that the sensitivity of our MPRA screen to identify causal variants from GWAS is between 14% and 22% (see Supplemental Experimental Procedures).</s><s>As $80% of causal GWAS variants are expected to act in regulatory regions, it is likely that we have missed a number of true functional variants below our assay's detection threshold and have thus created a resource website combining our MPRA results, PICS probability scores, erythroid chromatin and TF profiles, and population DHS and chromatin skew data (in heterozygous samples) for all 2,756 variants at the 75 loci so that multiple lines of evidence can be weighed before deciding to follow-up on any individual variant (http://www.bloodgenes.org/RBC_MPRA/).</s><s>For example, rs11865131 resides within the well-known HS-40 enhancer of the a-globin locus <ref type="bibr" target="#b15">(Hughes et al., 2013)</ref>, has a PICS probability of 18%, and shows a significant skew in reads for epigenomic modifications.</s><s>Although this variant is within a strongly AC (top 0.1%), it is sub-threshold for allelic skew in MPRA (FDR of 12%) and thus is likely a false-negative variant as a result.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Involvement of a GATA1 TF Complex at MPRA Functional Variants</head><p><s>Having identified 32 MFVs, we now investigate a few in greater detail and discuss their putative regulatory modalities.</s><s>First, in the third intron of SLC12A4, we identify a strongly conserved MFV (rs3785098) that falls within an enhancer occupied primarily by the AP-1 complex, which is known to be activated downstream from erythroid mitogens (Figure <ref type="figure" target="#fig_5">S4A</ref>) <ref type="bibr" target="#b8">(Erickson-Miller et al., 2000)</ref>.</s><s>Second, in the short intergenic region between FBXL20 and MED1, we identify an MFV (rs9901219) that is occupied by the ubiquitous transcriptional activator YY1 (Figure <ref type="figure" target="#fig_5">S4B</ref>).</s><s>Third, we identify an MFV (rs7123861) that falls inside a regulatory element that is silenced, based upon H3K27me3 levels, in erythroid cells but ubiquitously open in other cell types (Figure <ref type="figure" target="#fig_5">S4C</ref>).</s><s>Finally, near MARCH8 we identify multiple MFVs in high LD with the low-frequency sentinel variant rs901683.</s><s>Although interpreting loci with multiple MFVs is challenging, rs901682 is the most compelling and overlaps with a GATA1 occupancy site (Figure <ref type="figure" target="#fig_5">S4D</ref>).</s></p><p><s>Although we do not explore the exact mechanisms for these four MFVs further, we did investigate the ability of each variant to alter regulatory features in an endogenous setting by investigating each allele in DHS footprinting performed in heterozygous donors and cell lines <ref type="bibr" target="#b26">(Maurano et al., 2015)</ref>.</s><s>We found that the allele with higher activity in our MPRA had a significantly greater number of reads across it for three out of four MFVs (the 4 th had similar directionality, but the skew was not significant), which provides an initial confirmation of the endogenous regulatory capabilities of these MFVs (Figure <ref type="figure" target="#fig_5">S4E</ref>).</s></p><p><s>Given that 83% of MFVs in HEP open chromatin are within a GATA1 occupancy site, the major regulatory modality of RBC MFVs appears to involve GATA1 and its co-factors, and we focus our efforts on defining these variants and their likely mechanisms.</s><s>We first identify rs737092 in an erythroid enhancer element bound by GATA1 and numerous co-factors (TAL1, KLF1, LDB1, and NFE2) downstream of RBM38 (Figure <ref type="figure" target="#fig_5">4A</ref>).</s><s>In our reporter assay, the major T allele showed increased activity compared to the minor C allele in K562+GATA1 (FDR &lt; 1%) (Fig- <ref type="figure" target="#fig_5">ure 4E</ref>).</s><s>Rs737092 does not directly alter any known TF-binding motifs (Table <ref type="table">S4</ref>), but it is partially conserved and is located 3 bp from a conserved GATA1-binding motif (Figure <ref type="figure" target="#fig_5">4D</ref>).</s><s>Similarly, we identify rs4490057 in an erythroid enhancer element bound by GATA1 and TAL1 in the first intron of PGS1 (Figure <ref type="figure" target="#fig_5">4B</ref>).</s><s>Rs4490057's minor G allele had significantly higher activity compared to the major A in both K562 and K562+GATA1 (FDR &lt; 1%) (Figure <ref type="figure" target="#fig_5">4F</ref>).</s><s>Again, this variant does not appear to alter the core GATA1 motif but is instead 1 bp away and is predicted to slightly affect the extended GATA1/TAL1 motif (higher activity for the allele that improves the GATA1/TAL1 motif) (Figure <ref type="figure" target="#fig_5">4B</ref> and Table <ref type="table">S4</ref>).</s><s>We also identify the MFV rs1175550 within a strong erythroid enhancer bound by GATA1 and multiple cofactors (Figures <ref type="figure" target="#fig_5">4C and 4G</ref>).</s><s>This variant falls within the 2 nd intron of SMIM1, and although it also does not disrupt any known TFbinding motifs (Table <ref type="table">S4</ref>), it is 3 bp from a partially conserved GATA1/TAL1-binding motif.</s><s>In contrast to the other three variants, we observe that rs1546723, lying within an erythroid enhancer bound by GATA1 and TAL1 in the pseudogene CCDC162P, disrupts the TAL1 E box of a GATA1/TAL1-binding motif (higher activity for the allele that improves the TAL1 motif) (Figures <ref type="figure" target="#fig_5">4D and 4H</ref>).</s><s>Before performing further follow-up on these variants, we used individual luciferase reporter assays to confirm their effects on transcription in a larger genomic context (300-400 nucleotides) (Figure <ref type="figure" target="#fig_5">4I</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Isogenic Deletions Identify Multiple Target Genes at Each Locus</head><p><s>In order to investigate the regulatory capacity of the DNA elements containing these MFVs in an endogenous setting and identify target effector gene(s), we targeted three MFVs (rs737092, rs1175550, and rs1546723) with CRISPR/Cas9 genome editing and created isogenic clonal deletions across each MFV (median size was 13 nucleotides) (Figure <ref type="figure" target="#fig_6">S5</ref>).</s></p><p><s>For each deletion, we investigated the expression of all genes within $1 megabase that were expressed during normal human erythropoiesis (Table <ref type="table">S5</ref>).</s><s>For rs737092, both deletions identified RBM38 and RAE1 as potential target genes, although RBM38 was most strongly affected, consistent with looping observed between a fragment containing rs737092 and the RBM38 promoter in CD34 + HSPCs (Figures <ref type="figure" target="#fig_6">4A and 5A</ref>) <ref type="bibr" target="#b28">(Mifsud et al., 2015)</ref>.</s><s>In order to better account for heterogeneity resulting from expansion of single-cell clones, we used deletions across the other unlinked MFVs as cross controls.</s><s>We determined that RBM38 had a consistent strong knockdown, whereas changes in RAE1 expression were variable (Figure <ref type="figure" target="#fig_6">5A</ref>).</s><s>At rs1175550, we determined that the three nearest expressed genes, SMIM1, LRRC47, and CEP104, were affected, although SMIM1 showed the largest consistent suppression (Figure <ref type="figure" target="#fig_6">5B</ref>).</s><s>Downregulation of all three genes was also confirmed in cross controls (Figure <ref type="figure" target="#fig_6">5B</ref>).</s><s>This finding is consistent with previous population-based studies that show an association between an LD block containing rs1175550 with whole-blood SMIM1 mRNA expression and its surface protein expression on RBCs <ref type="bibr" target="#b6">(Cvejic et al., 2013;</ref><ref type="bibr" target="#b12">Haer-Wigman et al., 2015)</ref>.</s></p><p><s>At rs1546723, we initially found that the deletions showed substantially altered expression for a proximal gene, CD164, as well as moderately altered expression for two more distal genes, FOXO3 and FIG4, although differences in FOXO3 were not consistent in cross controls (Figure <ref type="figure" target="#fig_6">5C</ref>).</s><s>Importantly, looping data in CD34 + HSPCs cells identified a significant interaction between a fragment containing rs1546723 and the CD164 promoter, but not with either the FOXO3 or FIG4 promoters (Figure <ref type="figure" target="#fig_5">4D</ref>).</s></p><p><s>Overall, our finding that the deletion of small DNA elements containing each MFV affects multiple target genes, although generally only one to two genes are substantially affected, extends upon and is consistent with previous reports of comprehensive GWAS follow-up studies at particular genomic loci <ref type="bibr" target="#b3">(Claussnitzer et al., 2015;</ref><ref type="bibr" target="#b29">Musunuru et al., 2010)</ref>.</s><s>However, it is important to note that the sizes of the effects reported here are likely larger than those of the single-nucleotide changes at the MFVs themselves.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Altered TF Binding as a Putative Mechanism of Action</head><p><s>The observed overlap between MFVs and a GATA1 complex suggests that these four MFVs may alter transcriptional regulation by affecting the binding and/ or activity of erythroid TFs.</s><s>In order to investigate this possibility, we analyzed FAIRE-seq and ChIP-seq data for GATA1, TAL1, NFE2, and LDB1 in heterozygous donor-derived erythroblasts.</s></p><p><s>At rs1546723, the variant that alters a TAL1-binding site, we observe a significantly higher number of reads across the active A allele for TAL1, LDB1, and FAIRE-seq compared to the less active G allele, suggesting that rs1546723 substantially alters the binding of TAL1 and LDB1, but not GATA1, thus affecting transcription of its target genes (Figure <ref type="figure" target="#fig_7">6A</ref>).</s><s>Previous work has shown that this is indeed the case for other mutations that alter the E box component of a GATA1/TAL1 motif <ref type="bibr" target="#b55">(Wienert et al., 2015)</ref>.</s><s>For rs4490057, the variant that affects the extended GATA1 motif, we observe a substantially higher number of reads for both GATA1 and TAL1 across the allele with higher MRPA activity (Figure <ref type="figure" target="#fig_7">6B</ref>).</s><s>We also observe a GATA1 dosage-dependent increase for only the active allele (FDR &lt; 1%) (Figure <ref type="figure" target="#fig_5">4F</ref>).</s></p><p><s>In contrast to rs1546723 and rs4490057, neither rs1175550 nor rs737092 (PICS probability of 0.67 and 0.50, respectively) is predicted to disrupt the binding motif of any occupied TF TF-binding sites are highlighted proximal to the MFV.</s><s><ref type="bibr">(A and D)</ref> Interactions between a promoter and HindIII fragment identified from promoter capture Hi-C in CD34 + hematopoietic stem and progenitor cells (HSPCs) are shown.</s><s>(E-H) Activity scores for minor and major alleles of rs737092 (E), rs4490057 (F), rs1175550 (G), and rs1546723 (H) in the MPRA for the early (K562) and late (K562+GATA1) erythroid progenitor models are shown as boxplots.</s><s>Position of the variant in the reporter construct is indicated.</s><s>*FDR &lt; 1%.</s><s>(I) Correlations between max MPRA fold-change estimates for allelic skew in K562 cells and individual luciferase reporter fold-change estimates.</s></p><p><s>(Table <ref type="table">S4</ref>).</s><s>Indeed, the majority of non-coding PCVs do not alter known TF-binding sites <ref type="bibr" target="#b9">(Farh et al., 2015)</ref>, so it is currently unclear how variants like rs1175550 and rs737092 affect transcriptional regulation.</s><s>Recent studies have highlighted the importance of TF-complex preferences for specific nucleotide and tertiary DNA structures both within and outside of core binding motifs <ref type="bibr" target="#b22">(Levo et al., 2015;</ref><ref type="bibr" target="#b31">Panne et al., 2007)</ref>, so we predicted the allele-specific effects of these variants on DNA-shape characteristics (Figures <ref type="figure" target="#fig_7">6D-6F</ref>).</s><s>We determined that rs737092 and rs1175550 (and to a lesser extent rs4490057) significantly altered either the propeller or helix twists (ProT and HelT) at the edges of GATA1 or TAL1 motifs substantially more than a control of 382 common variants with highly similar localization (Figures <ref type="figure" target="#fig_7">S6C  and S6D</ref>).</s><s>Consistent with this evidence, the active alleles of rs1175550 and rs737092 show a significant increase in activity upon GATA1 overexpression (FDR &lt; 1%) (Figure <ref type="figure" target="#fig_5">4C</ref>), reads from ChIP-seq on GATA1 and cofactors favor the active allele of rs1175550 (inconsistent for rs737092, Figure <ref type="figure" target="#fig_7">6C</ref> and Table <ref type="table">S6</ref>), and the target genes of both variants are upregulated during terminal erythropoiesis <ref type="bibr">(Figures S6A and S6B)</ref>.</s><s>Although more work is needed to verify these mechanisms, our data suggest that MFVs can alter the binding and activity of GATA1 and co-factors either directly or by fine-tuning the shape of the DNA adjacent to the core binding motifs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RBM38 Is a Key Regulator of Alternative Splicing in Terminal Human Erythropoiesis</head><p><s>We performed functional follow-up on RBM38, the gene most strongly affected by the deletion of rs737092.</s><s>RBM38 (RNA-binding motif protein 38) is an RNA-binding protein that has previously been shown to play a key role in p53 activation <ref type="bibr" target="#b56">(Zhang et al., 2014)</ref>.</s><s>Because rs737092 was associated with RBC count and size <ref type="bibr">(MCV and MCH)</ref> in the original GWAS study <ref type="bibr" target="#b51">(van der Harst et al., 2012)</ref>, we performed a knockdown of RBM38 in primary erythroid cell culture (sh1 and sh2) to investigate its effects on erythroid differentiation and observed delayed differentiation in knockdown cells <ref type="bibr">(Figures 7A,</ref><ref type="bibr">7B,</ref><ref type="bibr">and S7A)</ref>.</s><s>This delayed maturation is likely to alter RBC size and count, as observed in the GWAS (van der <ref type="bibr" target="#b51">Harst et al., 2012)</ref>, consistent with our earlier findings on other factors associated with these traits <ref type="bibr" target="#b41">(Sankaran et al., 2012b)</ref>.</s></p><p><s>During normal human erythropoiesis, an extensive alternative splicing program of pre-mRNA occurs during the final stages of differentiation, and genes encoding key cell-cycle regulators and structural proteins are preferentially affected <ref type="bibr" target="#b33">(Pimentel et al., 2014)</ref>.</s><s>To test the extent to which RBM38 is necessary for Cell 165, 1530-1545, June 2, 2016 1539 correct alternative splicing in late-stage erythroblasts, we performed RNA-seq on day 16 control and RBM38 knockdown cells.</s><s>We first confirmed that both control and knockdown cells resembled late-stage erythroblasts (Figure <ref type="figure">S7B</ref>).</s><s>We observed 34 exon-splicing events that were altered by RBM38 knockdown <ref type="bibr">(Figures 7C and 7D)</ref>.</s><s>Over half of these splicing events are observed to the same extent (&gt;20% change in exon inclusion) during normal erythropoiesis, suggesting that RBM38 plays a key role in regulating a subset of the alternative splicing program in human erythropoiesis (Figure <ref type="figure">7D</ref>).</s><s>It is currently unclear which alternative splicing event(s) are functionally related to the block in differentiation, although several attractive targets were observed.</s><s>Interestingly, the 2 nd most differentially spliced exon upon RBM38 knockdown is exon 16 of EPB41, and its inclusion is concurrent with a partial exclusion of exon 14 (Figures <ref type="figure">7C, 7E</ref>, and S7C), consistent with recent work <ref type="bibr" target="#b13">(Heinicke et al., 2013)</ref>.</s></p><p><s>During normal human erythroid differentiation, exon 16 is preferentially included in more mature stages and is required for synthesis of the mature band 4.1R protein, a membrane skeletal protein that is critical for proper stability of the erythrocyte (Figure <ref type="figure">7C</ref>) <ref type="bibr" target="#b33">(Pimentel et al., 2014)</ref>.</s><s>Patients with hereditary elliptocytosis (HE) resulting from mutations in exon 16 of EPB41 have a hemolytic anemia associated with membrane instability, which can result in alteration of various RBC parameters <ref type="bibr" target="#b4">(Conboy et al., 1993;</ref><ref type="bibr" target="#b44">Shi et al., 1999)</ref>.</s><s>Thus, the association of rs737092 with RBC traits may be due to differences in EPB41 exon 16 inclusion and resultant variation in erythrocyte membrane stability in the general population that is more subtle than that observed in HE.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>As there is currently no gold standard approach to systematically screen for functional GWAS variants, we developed and applied a high-throughput MPRA to simultaneously screen all variants identified from a GWAS of RBC traits for regulatory function.</s><s>Our assay was capable of identifying endogenous erythroid regulatory elements and conservatively identified 32 MFVs representing 23 ($30%) of the original GWAS hits where we predict that between 10 and 16 are causally related to the original phenotypes.</s><s>By complementing these results with genetic fine mapping, open chromatin annotations, TF occupancy profiling, motif databases, functional predictive algorithms, CRISPR/Cas9 genome editing, and target gene modulation in primary cell culture, we identify six variants that have concordant allelic skew in DHS or TF profiling, suggest regulatory mechanisms for four variants, show that three variants lie within endogenous enhancers, determine three high-confidence target genes, and finally link one variant back to the original phenotype.</s><s>This method provides a novel approach for GWAS follow-up and can be applied to any GWAS where the relevant cell type(s) can be identified.</s><s>Alternatively, MPRA for specific GWAS can be performed across a panel of cell types implicated in the disease or trait of interest to help delineate variants that may affect regulatory activity in a particular lineage.</s><s>Given the scalability of our MPRA and the availability of corresponding epigenomic profiles for numerous relevant primary cell types <ref type="bibr" target="#b19">(Kundaje et al., 2015)</ref>, we envision that our approach could be applied across a larger number of GWAS studies, greatly improving the throughput of functional variant identification and helping to define the largely enigmatic mechanisms of action underlying GWAS results.</s><s>Moreover, MPRA could prove especially useful when used in conjunction with emerging approaches that allow for systematic disruption of endogenous functional elements but that cannot assess allele-specific variation <ref type="bibr" target="#b18">(Korkmaz et al., 2016)</ref>.</s></p><p><s>There are a number of limitations and considerations to keep in mind when interpreting our results and the general utility of MPRAs for GWAS follow-up.</s><s>First, given that we estimate a PPV of 32%-50%, this means that at best only 1 out of every 2 variants identified here will be causal, and additional experiments are required to link them back to the original phenotype.</s><s>Second, as we only estimate a sensitivity of 14%-22% and $80% of GWAS variants likely act by affecting transcriptional regulation at enhancer or promoter regions, our screen undoubtedly has a large number of false negatives.</s><s>Fortunately, improvements in MRPA technology, such as the ability to detect smaller effect sizes by the inclusion of more barcodes <ref type="bibr" target="#b32">(Patwardhan et al., 2012;</ref><ref type="bibr">Tewhey et al., 2016 [this issue of Cell]</ref>), longer genomic contexts <ref type="bibr" target="#b52">(Vockley et al., 2015)</ref>, and different promoters or across various cell types/stages will likely improve upon the sensitivity reported here.</s><s>Third, MPRA is not currently configured to detect functional variants in haplotypes containing multiple variants that may be jointly causal and fall within more than one regulatory element <ref type="bibr" target="#b5">(Corradin et al., 2014;</ref><ref type="bibr" target="#b52">Vockley et al., 2015)</ref>.</s><s>These variants are likely missed by our approach.</s><s>Fourth, MPRA should be thought of primarily as a screen to generate a reduced set of leads for PCVs.</s><s>Determining the causality of any single regulatory variant requires exhibiting molecular functionality, identifying target gene(s), and linking these gene(s) back to the original phenotype.</s></p><p><s>One key finding from our study is that a subset of MFVs appear to act in a common regulatory pathway involving the master regulator GATA1, similar to findings from studies implicating master TFs in other cell types <ref type="bibr" target="#b9">(Farh et al., 2015;</ref><ref type="bibr" target="#b29">Musunuru et al., 2010;</ref><ref type="bibr" target="#b42">Schaub et al., 2012;</ref><ref type="bibr" target="#b45">Soccio et al., 2015)</ref>.</s><s>Interestingly, we determined that most of these variants did not disrupt but were in close proximity to GATA1 and TAL1 binding sites, consistent with the results from a recent GWAS follow-up that found that only 7%-13% of PCVs disrupt a known TF-binding motif but 26% are proximal to the binding motifs of specific TFs.</s><s>Although more evidence is required for a definitive mechanism, our results suggest that these variants affect GATA1 and co-factor binding or activity by altering the DNA shape in the sequence-flanking core-binding motifs <ref type="bibr" target="#b22">(Levo et al., 2015;</ref><ref type="bibr">Figure 7</ref>. RBM38 Is Required for a Subset of Alternative Splicing Events during Terminal Human Erythropoiesis (A) We used two independent short hairpin RNAs (sh1 and sh2) to knockdown RBM38 along with one control hairpin (shLuc).</s><s>FACS analyses of erythroid markers CD71 and CD235a indicate a block in differentiation that occurs at day 16 and continues into day 19.</s><s>Percentage of live cells in each quadrant is represented by a mean and SD across three replicate experiments from independent donors (two replicates at day 19).</s><s>(B) Representative images of May-Grunwald-Giemsa-stained cytospins at day 16 of culture (633 objective in oil).</s><s>(C and D) RNA-seq was performed on cDNA derived from day 16 cells.</s><s>A heatmap of exons with a &gt;20% change in percentage spliced in (PSI) shared between RBM38 knockdown and normal erythropoiesis is shown in (C).</s><s>A Venn diagram of the number of differentially spliced exons shared between normal human erythropoiesis and RBM38 knockdown is shown in (D).</s><s>(E) Semiquantitative RT-PCR verifies the loss of EPB41 exon 16 inclusion following RBM38 knockdown at day 16 of differentiation.</s><s><ref type="bibr" target="#b31">Panne et al., 2007)</ref>.</s><s>This finding is important in the context of the RBC and its associated disorders, as mutations that impact GATA1 have been identified in severe Mendelian disorders, such as Diamond-Blackfan anemia <ref type="bibr" target="#b23">(Ludwig et al., 2014;</ref><ref type="bibr" target="#b39">Sankaran et al., 2012a)</ref>, where erythropoiesis is globally perturbed.</s><s>In a complementary manner, mutations that disrupt canonical GATA1 motifs at key regulatory elements have been found in patients with various congenital forms of anemia <ref type="bibr" target="#b1">(Campagna et al., 2014;</ref><ref type="bibr" target="#b17">Kaneko et al., 2014;</ref><ref type="bibr" target="#b25">Manco et al., 2000;</ref><ref type="bibr" target="#b46">Solis et al., 2001)</ref>.</s><s>Because mutations in both GATA1 itself and its canonical binding motif result in such severe phenotypes, it is perhaps not surprising that common genetic variants associated with small changes in RBC production act not by critically disrupting the binding motif itself but instead by subtly altering the binding and activity of GATA1 and co-factors, resulting in mild to moderate changes in the expression of target gene(s).</s><s>Consistent with this notion, rs2814778, one of the most wellknown variants subject to positive selection, directly alters a canonical GATA1 motif, completely disrupting expression of the Duffy blood group on the RBC surface and conferring resistance to Plasmodium vivax malaria <ref type="bibr" target="#b35">(Reich et al., 2009;</ref><ref type="bibr" target="#b50">Tournamille et al., 1995)</ref>.</s></p><p><s>Defective erythropoiesis appears to be the most common proximal pathophysiological mechanism of anemia worldwide <ref type="bibr" target="#b37">(Sankaran and Weiss, 2015)</ref>.</s><s>Here, we identified multiple new potential regulators of erythropoiesis (SMIM1, RBM38, and CD164).</s><s>Further study of these and other MFVs identified by MPRA, as well as their associated genes, will likely yield further biological insight into human erythropoiesis, potentially informing the development of better therapies for various forms of anemia.</s><s>More generally, the addition of high-throughput variant screening assays, such as the one employed here and by <ref type="bibr" target="#b49">Tewhey et al. (2016)</ref>, into the GWAS follow-up toolbox holds promise to accelerate both our understanding of numerous human disorders and the development of potential therapeutic applications <ref type="bibr" target="#b36">(Sankaran and Orkin, 2013)</ref>.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Designing and Verifying an MPRA as a GWAS Screening Tool (A) Overview of the MPRA.</s><s>Oligonucleotides separately containing each variant were synthesized with restriction enzyme cut sites and multiple barcodes, a minimal promoter and ORF were ligated between the sites, and the pooled plasmid library containing $231,000 constructs was transfected into erythroid cells.</s><s>(B) Greater than 80% of bar codes were highly represented in the plasmid library.</s><s>(C) Representative plot showing that MPRA activity (mRNA/DNA) is highly correlated between two replicates for the top 50% of constructs with minimal transcriptional capacity.</s><s>The average Pearson correlations across all six K562 and four K562+GATA1 replicates (compared separately) are reported.</s></p></div></figDesc><graphic coords="4,279.23,111.79,89.19,82.45" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. RBC Trait-Associated Variants Are Enriched for Erythroid Regulatory Regions</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>(Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Identifying Erythroid Regulatory Elements and MPRA Functional Variants (A) Activity boxplots of the five unique positive control variants.</s><s>Constructs with intact GATA1-binding sites (Ref) show increased activity when compared with broken binding sites (Mut).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. Delineating the Genomic Context of the MFVs rs737092, rs4490057, rs1175550, and rs1546723 (A-D) Location of the variants rs737092 (A), rs4490057 (B), rs1175550 (C), and rs1546723 (D) are shown in context with the neighboring genes.</s><s>NDRs, H3K27ac histone modifications, and TF occupancy profiles for LDB1, TAL1, GATA1, NFE2, and KLF1 are displayed for HEPs in normalized reads per million.</s><s>Predicted (legend continued on next page) Cell 165, 1530-1545, June 2, 2016 1537</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 5 .</head><label>5</label><figDesc><div><p><s>FIG4 SMPD2</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 6 .</head><label>6</label><figDesc><div><p><s>Figure 6.</s><s>Allele-Specific Binding of Erythroid TFs in Individuals Heterozygous for MFVs(A-C) The percentage of reads from ChIP-seq experiments in HEP cells derived from heterozygous donors mapping to either the major (orange) or minor (blue) alleles is shown for rs1546723 (A), rs4490057 (B), and rs1175550 (C).</s><s>In each case, allelic skew across all heterozygous donors for the bound erythroid TFs is consistent with the directionality of each variant in the MPRA.</s><s>(D-F) A machine-learning algorithm was applied to predict changes in the DNA shape (MGW, minor groove width; Roll, DNA roll; HelT, helix twist; and ProT, propeller twist) at surrounding nucleotides for rs737092 (D), rs4490057 (E), and rs1175550 (F).</s><s>*p value &lt; 0.05, **p value &lt; 0.001, ***p value &lt; 10 À8 from a two-tailed Student's t test.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="1,55.16,172.69,285.82,285.68" type="bitmap" /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>We would like to thank members of the Sankaran Lab and numerous colleagues for valuable comments and discussions.</s><s>This work was supported by a Broad Institute/Boston Children's Hospital collaborative grant and by the National Institutes of Health grants R01 DK103794, R21 HL120791 (to V.G.S.), and R01 HG006785 (to T.S.M.).</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>(B) Kernel densities for positive controls as well as for ACs and nACs containing GWAS variants.</s><s>ACs represent 4% (555/15,612) of the MPRA library.</s><s>(C) Presence or absence of specific 6-mers can effectively be used to discriminate between ACs and nACs using a support vector machine model.</s><s>(D) The 6-mers that are most strongly weighted toward ACs are similar to ETS/FLI1, GATA1, TAL1, CREB, and NFE2/AP1 motifs.</s><s>(E) ACs are enriched for erythroid DHS as well as for occupancy sites of the erythroid TFs, GATA1 and TAL1, when compared to low-activity constructs (nACs) and $10,000 background sentinel GWAS hits.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EXPERIMENTAL PROCEDURES</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reproducible Research</head><p><s>We have provided the raw data and R scripts necessary to reproduce the primary MPRA analyses (http://www.bloodgenes.org/RBC_MPRA/).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Design and Synthesis of an MPRA</head><p><s>Seventy-five GWAS hits associated with RBC traits were obtained from a recent study <ref type="bibr" target="#b51">(van der Harst et al., 2012)</ref>.</s><s>SNPs in high LD with sentinel GWAS hits were identified from the CEU population of the 1000 Genomes Project Phase 1 Version 3. One hundred and forty-five nucleotide constructs were designed by placing, for each of the 2,756 variants, major and minor alleles into the construct such that 1/3, 1/2, and 2/3 of the total length was 5 0 of the variant (Table <ref type="table">S1</ref>).</s></p><p><s>An oligonucleotide library containing the 145 nucleotide genomic regions with 14 barcodes each, separated by KpnI-XbaI sites and flanked by constant primer sites, was synthesized on an array (Agilent).</s><s>The oligonucleotide library was then PCR amplified and cloned into the pMPRA1 plasmid backbone with a minP-luc2 insert, as previously described <ref type="bibr" target="#b27">(Melnikov et al., 2012)</ref>.</s><s>The resulting plasmid library was introduced into K562 or K562+GATA1 cells using a Nucleofector II Device with Cell Line Kit V (Lonza).</s><s>Forty-eight hours later, total RNA was harvested, and the barcodes were isolated by RT-PCR, as previously described <ref type="bibr" target="#b27">(Melnikov et al., 2012)</ref>.</s><s>The barcodes were then sequenced and counted using an Illumina HiSeq 2500 sequencer.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analysis of a High-Throughput Variant Screen</head><p><s>A total of six replicates were performed for the MPRA screen in K562 cells and four replicates in K562+GATA1 cells.</s><s>A pseudocount of 1 was added to DNA and RNA barcode counts that were subsequently normalized to counts per million (CPM) and log 2 transformed.</s><s>Barcodes with fewer than 8 transformed counts were removed from each replicate.</s><s>Activity was calculated as the ratio of RNA and DNA counts.</s><s>Replicates were quantile normalized and combined as independent observations.</s><s>ACs were defined as constructs that showed significantly higher activity (FDR &lt; 1%, derived on all constructs and SWs) when compared with the activity distribution of all other constructs by a one-sided Mann-Whitney-U test.</s><s>To identify MFVs, we used a two-sided Mann-Whitney-U test for K562 and K562+GATA1 MPRAs separately to compare activity between the constructs containing the major allele of the variant with those containing the minor allele (FDR &lt; 1%, derived on all constructs and SWs).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Additional Analyses and Experimental Procedures</head><p><s>In-depth experimental and analytic methods are available in the Supplemental Experimental Procedures.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SUPPLEMENTAL INFORMATION</head><p><s>Supplemental Information includes Supplemental Experimental Procedures, seven figures, and seven tables and can be found with this article online at http://dx.doi.org/10.1016/j.cell.2016.04.048.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AUTHOR CONTRIBUTIONS</head><p><s>V.G.S., T.S.M., J.C.U., and S.K.N. designed the study.</s><s>J.C.U., S.K.N., V.G.S., and T.S.M. wrote the manuscript with input from all authors.</s><s>J.C.U., T.S.M., and R.D. performed all bioinformatics analyses.</s><s>S.K.N. performed all followup experiments.</s><s>L.W., X.Z., P.R., and A.M. performed MPRA library transfections and sequencing.</s><s>F.C.G. prepared cell lines for MPRAs.</s><s>P.M. provided assistance with genome editing.</s><s>V.G.S. supervised all experimental and analytic aspects of this work.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Kamran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lessard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fujiwara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Shao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Canver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pinello</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">342</biblScope>
			<biblScope unit="page" from="253" to="257" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Campagna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>De Bie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schmitz-Abe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sweeney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Sendamarai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Heeney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Yntema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kannengiesser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Grandchamp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hematol</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="315" to="319" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Leveraging cross-species transcription factor binding site patterns: from diabetes risk loci to disease mechanisms</title>
		<author>
			<persName><forename type="first">M</forename><surname>Claussnitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Dankel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Klocke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Grallert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Glunk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Berulava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Oskolkov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fadista</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ehlers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="343" to="358" />
			<date type="published" when="2014">2014</date>
			<publisher>DIAGRAM+Consortium</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">1543 obesity variant circuitry and adipocyte browning in humans</title>
		<author>
			<persName><forename type="first">M</forename><surname>Claussnitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Dankel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Quon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Meuleman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Haugen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Glunk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Sousa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Beaudry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Puviindran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="page" from="895" to="907" />
			<date type="published" when="2015-06-02">2015. June 2, 2016</date>
		</imprint>
	</monogr>
	<note>FTO Cell</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">An isoform-specific mutation in the protein 4.1 gene results in hereditary elliptocytosis and complete deficiency of protein 4.1 in erythrocytes but not in nonerythroid cells</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Conboy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Chasis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Winardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tchernia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">W</forename><surname>Kan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mohandas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="77" to="82" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits</title>
		<author>
			<persName><forename type="first">O</forename><surname>Corradin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Saiakhova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Akhtar-Zaidi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Myeroff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Willis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cowper-Sal Lari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lupien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Markowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Scacheri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1" to="13" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">SMIM1 underlies the Vel blood group and influences red blood cell traits</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cvejic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Haer-Wigman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Stephens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kostadima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Smethurst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Frontini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Van Den Akker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bertone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bielczyk-Maczy Nska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Farrow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="542" to="545" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Beyond GWASs: illuminating the dark road from association to function</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Beesley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>French</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Dunning</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hum. Genet</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="779" to="797" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Erickson-Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Pelus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Lord</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stem Cells</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="366" to="373" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Genetic and epigenetic fine mapping of causal autoimmune disease variants</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Farh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Marson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kleinewietfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Housley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Beik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Shoresh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Whitton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Ryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Shishkin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">518</biblScope>
			<biblScope unit="page" from="337" to="343" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Targeted application of human genetic variation can improve red blood cell production from stem cells</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Giani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fiorini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wakabayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Salem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Jobaliya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Regan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Ulirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Steinberg-Shemer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Stem Cell</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="73" to="78" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gusev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Trynka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Finucane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Vilhja ´lmsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ripke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bulik-Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Stahl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Schizophrenia Working Group of the Psychiatric Genomics Consortium; SWE-SCZ Consortium; Schizophrenia Working Group of the Psychiatric Genomics Consortium; SWE-SCZ Consortium</title>
				<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="535" to="552" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Impact of genetic variation in the SMIM1 gene on Vel expression levels</title>
		<author>
			<persName><forename type="first">L</forename><surname>Haer-Wigman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Stegmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Solati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ait Soussan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Beckers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Van Der Harst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Hulst-Sundermeijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ligthart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Van Rhenen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schepers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transfusion</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1457" to="1466" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The RNA binding protein RBM38 (RNPC1) regulates splicing during late erythroid differentiation</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Heinicke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nabet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Van Zalen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Cieply</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Carstens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e78031</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Halverson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Raza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Galili</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jaffray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="3246" to="3253" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">High-resolution analysis of cis-acting regulatory networks at the a-globin locus</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Lower</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dunham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De Gobbi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Sloane-Stanley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mcgowan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ragoussis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Vernimmen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Gibbons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Higgs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Philos. Trans. R. Soc. Lond. B Biol. Sci</title>
		<imprint>
			<biblScope unit="volume">368</biblScope>
			<date type="published" when="2013">2013. 20120361</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">A spectral approach integrating functional genomic annotations for coding and noncoding variants</title>
		<author>
			<persName><forename type="first">I</forename><surname>Ionita-Laza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mccallum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Buxbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="214" to="220" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kaneko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Furuyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujiwara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Harigae</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shibahara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="252" to="261" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9</title>
		<author>
			<persName><forename type="first">G</forename><surname>Korkmaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lopes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Ugalde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Nevedomskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Myacheva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zwart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Elkon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Agami</forename></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Biotechnol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="192" to="198" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Integrative analysis of 111 reference human epigenomes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kundaje</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Meuleman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ernst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilenky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Heravi-Moussavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kheradpour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ziller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Roadmap Epigenomics Consortium</title>
				<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">518</biblScope>
			<biblScope unit="page" from="317" to="330" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Discriminative prediction of mammalian enhancers from DNA sequence</title>
		<author>
			<persName><forename type="first">D</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Karchin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Beer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="2167" to="2180" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">A method to predict the impact of regulatory variants from DNA sequence</title>
		<author>
			<persName><forename type="first">D</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">U</forename><surname>Gorkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Strober</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Asoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Mccallion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Beer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="955" to="961" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Unraveling determinants of transcription factor binding outside the core binding site</title>
		<author>
			<persName><forename type="first">M</forename><surname>Levo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Zalckvar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sharon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Dantas Machado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kalma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lotam-Pompan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Weinberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Yakhini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rohs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Segal</surname></persName>
		</author>
		<idno>1410.2</idno>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Altered translation of GATA1 in Diamond-Blackfan anemia</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Gazda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Eng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Eichhorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Thiru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ghazvinian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">I</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Gotlib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Beggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Sieff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="748" to="753" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Genome-wide association study follow-up identifies cyclin A2 as a regulator of the transition through cytokinesis during terminal erythropoiesis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wakabayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Eng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Ulirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Lodish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hematol</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="386" to="391" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">A new PKLR gene mutation in the R-type promoter region affects the gene transcription causing pyruvate kinase deficiency</title>
		<author>
			<persName><forename type="first">L</forename><surname>Manco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Ribeiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Ma ´ximo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Almeida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Freitas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Barbot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Abade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tamagnini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Haematol</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="993" to="997" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Large-scale identification of sequence variants influencing human transcription factor occupancy in vivo</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Maurano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Haugen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sandstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vierstra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shafer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kaul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Stamatoyannopoulos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1393" to="1401" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay</title>
		<author>
			<persName><forename type="first">A</forename><surname>Melnikov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Murugan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tesileanu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rogov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Feizi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gnirke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Callan</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Kinney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Biotechnol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="271" to="277" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C</title>
		<author>
			<persName><forename type="first">B</forename><surname>Mifsud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tavares-Cadete</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sugar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schoenfelder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Wingett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Andrews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Grey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Ewels</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="598" to="606" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus</title>
		<author>
			<persName><forename type="first">K</forename><surname>Musunuru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Strong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Frank-Kamenetsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ahfeldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Sachs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kuperwasser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Ruda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">466</biblScope>
			<biblScope unit="page" from="714" to="719" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Densely interconnected transcriptional circuits control cell states in human hematopoiesis</title>
		<author>
			<persName><forename type="first">N</forename><surname>Novershtern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Subramanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Lawton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Mak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">N</forename><surname>Haining</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Mcconkey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Habib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yosef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="296" to="309" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">An atomic model of the interferon-beta enhanceosome</title>
		<author>
			<persName><forename type="first">D</forename><surname>Panne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Maniatis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Harrison</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="1111" to="1123" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Massively parallel functional dissection of mammalian enhancers in vivo</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Patwardhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Hiatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Witten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>May</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Andrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Cooper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Biotechnol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="265" to="270" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">A dynamic alternative splicing program regulates gene expression during terminal erythropoiesis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Pimentel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Parra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ghanem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>An</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mohandas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pachter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Conboy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="4031" to="4042" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Mapping rare and common causal alleles for complex human diseases</title>
		<author>
			<persName><forename type="first">S</forename><surname>Raychaudhuri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="page" from="57" to="69" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene</title>
		<author>
			<persName><forename type="first">D</forename><surname>Reich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Nalls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Kao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Akylbekova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tandon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Patterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mullikin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Hsueh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Coresh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e1000360</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Genome-wide association studies of hematologic phenotypes: a window into human hematopoiesis</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Orkin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Genet. Dev</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="339" to="344" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Anemia: progress in molecular mechanisms and therapies</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Weiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="221" to="230" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Menne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Akie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lettre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Van Handel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K A</forename><surname>Mikkola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Hirschhorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Cantor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Orkin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">322</biblScope>
			<biblScope unit="page" from="1839" to="1842" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ghazvinian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Do</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Thiru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Vergilio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Beggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Sieff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Orkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Nathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Lander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Gazda</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia</title>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="2439" to="2443" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sicinska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Eng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Patterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Metcalf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Natkunam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Orkin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Dev</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2075" to="2087" />
			<date type="published" when="2012">2012b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Schaub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Boyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kundaje</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Batzoglou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Snyder</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1748" to="1759" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">T</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Afzal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Coller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Chasis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Parra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Paszty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Walensky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="331" to="340" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Genetic variation determines PPARg function and anti-diabetic drug response in vivo</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Soccio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Rajapurkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Safabakhsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Marinis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Dispirito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Emmett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Briggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Everett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="33" to="44" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><surname>Solis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Aizencang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Astrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Bishop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Desnick</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria</title>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="753" to="762" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">A gene atlas of the mouse and human protein-encoding transcriptomes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wiltshire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Batalov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Ching</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Block</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Soden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hayakawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kreiman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="s">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="6062" to="6067" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Direct identification of hundreds of expression-modulating variants using a multiplexed reporter assay</title>
		<author>
			<persName><forename type="first">R</forename><surname>Tewhey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kotliar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Winnicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Reilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Andersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Mikkelsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Lander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Schaffner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Sabeti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="page" from="1519" to="1529" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tournamille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Colin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Cartron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Van Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="224" to="228" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Altered chromatin occupancy of master regulators underlies evolutionary divergence in the transcriptional landscape of erythroid differentiation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Ulirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Lacy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>An</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mohandas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Mikkelsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Van Der Harst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mateo</forename><surname>Leach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Rendon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Verweij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sehmi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Elling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Allayee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="369" to="375" />
			<date type="published" when="2012">2014. e1004890. 2012</date>
		</imprint>
	</monogr>
	<note>Nature</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Massively parallel quantification of the regulatory effects of noncoding genetic variation in a human cohort</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Vockley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Majoros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nodzenski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Scholtens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Hayes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Lowe</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Reddy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1206" to="1214" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Insight into the GATA1 transcriptional activity through interrogation of cis elements disrupted in human erythroid disorders</title>
		<author>
			<persName><forename type="first">A</forename><surname>Wakabayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Ulirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fiorini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yasuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Choudhuri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mcdonel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Zon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.1521754113</idno>
		<ptr target="http://dx.doi.org/10.1073/pnas.1521754113" />
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="4434" to="4439" />
			<date type="published" when="2016-04-04">2016. April 4, 2016</date>
		</imprint>
	</monogr>
	<note>Published online</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">The NHGRI GWAS Catalog, a curated resource of SNP-trait associations</title>
		<author>
			<persName><forename type="first">D</forename><surname>Welter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Macarthur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Morales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Burdett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Junkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Klemm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Flicek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Manolio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hindorff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Parkinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="D1001" to="D1006" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Editing the genome to introduce a beneficial naturally occurring mutation associated with increased fetal globin</title>
		<author>
			<persName><forename type="first">B</forename><surname>Wienert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Funnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Norton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Pearson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Wilkinson-White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vadolas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Porteus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Quinlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Crossley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">7085</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Mice deficient in Rbm38, a target of the p53 family, are susceptible to accelerated aging and spontaneous tumors</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Cardiff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Imai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wisner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chen</forename></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="18637" to="18642" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Predicting effects of noncoding variants with deep learning-based sequence model</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">G</forename><surname>Troyanskaya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Methods</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">1545</biblScope>
			<date type="published" when="2015-06-02">2015. June 2. 2016</date>
		</imprint>
	</monogr>
	<note>Cell</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
